Bank of America Corp DE Lowers Position in Rapport Therapeutics (NASDAQ:RAPP)
Bank of America Corp DE cut its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 65.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 6,578 shares of the company’s stock after selling 12,532 shares during the quarter. Bank of America Corp DE’s holdings in Rapport Therapeutics were worth $117,000 as of its […]
Bank of America Corp DE cut its stake in Rapport Therapeutics (NASDAQ:RAPP – Free Report) by 65.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 6,578 shares of the company’s stock after selling 12,532 shares during the quarter. Bank of America Corp DE’s holdings in Rapport Therapeutics were worth $117,000 as of its […]
